Disease | breast cancer |
Symptom | C0080032|malignant pleural effusion |
Sentences | 8 |
PubMedID- 21565923 | Efficacy of pleurodesis for malignant pleural effusions in breast cancer patients. |
PubMedID- 22964933 | Clinical and pathological factors influencing the survival of breast cancer patients with malignant pleural effusion. |
PubMedID- 23405099 | The cell line was established in j. kurebayashi's lab from the malignant pleural effusion of a breast cancer patient with an inflammatory skin metastasis . |
PubMedID- 24887236 | The kpl4 cell line was isolated from the malignant pleural effusion of a breast cancer patient with an inflammatory skin metastasis; these cells are resistant to trastuzumab in female athymic nude mice . |
PubMedID- 26539407 | A 59-year-old woman was found to have recurrent hormone receptor positive and her2 positive breast cancer with malignant pleural effusion and bony metastases. |
PubMedID- 20051960 | The kpl-4 cell line was isolated from the malignant pleural effusion of a breast cancer patient with an inflammatory skin metastasis; in female athymic nude mice, kpl-4 cells are mostly resistant to trastuzumab (kurebayashi et al, 1999). |
PubMedID- 23826463 | malignant pleural effusion in breast cancer 12 years after mastectomy that was successfully treated with endocrine therapy. |
PubMedID- 23992330 | The kpl-4 cell line, isolated from the malignant pleural effusion of a breast cancer patient with an inflammatory skin metastasis and resistant to trastuzumab in female athymic nude mice , represents another model of intrinsic resistance to trastuzumab, due to p95her2 fragment overexpression. |
Page: 1